Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $89,703.03 -2.90%
  • Ethereum $3,040.80 -4.29%
  • BNB $885.72 -2.31%
  • Optimism $0.30 -7.05%
  • Arbitrum $0.20 -6.22%
  • Solana $133.10 -5.06%
  • Polygon $0.22 +2.77%
  • Cosmos $2.21 -4.71%
  • Avalanche $13.27 -7.92%
  • Bitcoin $89,703.03 -2.90%
  • Ethereum $3,040.80 -4.29%
  • BNB $885.72 -2.31%
  • Optimism $0.30 -7.05%
  • Arbitrum $0.20 -6.22%
  • Solana $133.10 -5.06%
  • Polygon $0.22 +2.77%
  • Cosmos $2.21 -4.71%
  • Avalanche $13.27 -7.92%
Home / X4 Pharmaceuticals / investors

X4 Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
5
17
X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Acorn Bioventures Yes Post-IPO Equity
Lumira Ventures Yes Post-IPO Equity
New Enterprise Associates Yes Post-IPO Equity
Cormorant Asset Management Yes Series B
Hercules Capital - Post-IPO Equity
AXA Investment Managers - Post-IPO Equity
Bain Capital Life Sciences - Post-IPO Equity
OrbiMed - Post-IPO Equity
Abingworth - Post-IPO Equity
Altium Capital - Post-IPO Equity
Driehaus Capital Management - Post-IPO Equity
Ikarian Capital - Post-IPO Equity
Lincoln Park Capital Fund - Post-IPO Equity
Monashee Investment Management - Post-IPO Equity
Sio Capital Management - Post-IPO Equity
Thynk Capital, LLC. - Series A
SV Health Investors - Seed

Contact

Cambridge,Massachusetts,United States
+1 857 529 8300
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions